Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
Kojima Y, Shimoi T, Seo T, Yazaki S, Okuya T, Ohtake Y, Okuma HS, Shimomura A, Nishikawa T, Tanioka M, Sudo K, Noguchi E, Tamura K, Yoshida A, Iwata S, Kobayashi E, Kawai A, Fujiwara Y, Yonemori K.
Kojima Y, et al. Among authors: tanioka m.
Oncology. 2022;100(7):370-375. doi: 10.1159/000524500. Epub 2022 Apr 11.
Oncology. 2022.
PMID: 35405680